These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30579284)

  • 1. Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry.
    Sheehan JP; Grills I; Chiang VL; Dong H; Berg A; Warnick RE; Kondziolka D; Kavanagh B
    J Neurosurg; 2019 Dec; 131(6):1848-1854. PubMed ID: 30579284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-life trajectories after stereotactic radiosurgery for brain metastases.
    Bunevicius A; Lavezzo K; Shabo L; McClure J; Sheehan JP
    J Neurosurg; 2021 Jun; 134(6):1791-1799. PubMed ID: 32650308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life is maintained using Gamma Knife radiosurgery: a prospective study of a brain metastases patient cohort.
    Skeie BS; Eide GE; Flatebø M; Heggdal JI; Larsen E; Bragstad S; Pedersen PH; Enger PØ
    J Neurosurg; 2017 Mar; 126(3):708-725. PubMed ID: 27058206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry.
    Michalopoulos GD; Katsos K; Grills IS; Warnick RE; McInerney J; Attia A; Timmerman R; Chang E; Andrews DW; D'Ambrosio AL; Cobb WS; Pouratian N; Spalding AC; Walter K; Jensen RL; Bydon M; Asher AL; Sheehan JP
    J Neurosurg; 2024 May; 140(5):1223-1232. PubMed ID: 37948684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery.
    Verhaak E; Gehring K; Hanssens PEJ; Sitskoorn MM
    J Neurooncol; 2019 Jul; 143(3):537-546. PubMed ID: 31073966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
    Koiso T; Yamamoto M; Kawabe T; Watanabe S; Sato Y; Higuchi Y; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):2-10. PubMed ID: 27903177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry.
    Asher AL; Alvi MA; Bydon M; Pouratian N; Warnick RE; McInerney J; Grills IS; Sheehan J
    J Neurooncol; 2021 Apr; 152(2):299-311. PubMed ID: 33481148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
    Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
    BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery.
    Bian SX; Routman D; Liu J; Yang D; Groshen S; Zada G; Trakul N; Wong MK; Yu C; Chang EL
    J Neurosurg; 2016 Dec; 125(Suppl 1):31-39. PubMed ID: 27903181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2020 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.
    Aoyama H; Tago M; Kato N; Toyoda T; Kenjyo M; Hirota S; Shioura H; Inomata T; Kunieda E; Hayakawa K; Nakagawa K; Kobashi G; Shirato H
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1388-95. PubMed ID: 17674975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
    J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
    J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes.
    Rahimy E; Dudley SA; von Eyben R; Pollom EL; Seiger K; Modlin L; Wynne J; Fujimoto D; Jacobs LR; Chang SD; Gibbs IC; Hancock SL; Adler JR; Li G; Choi CYH; Soltys SG
    Am J Clin Oncol; 2021 Nov; 44(11):588-595. PubMed ID: 34670228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.
    Ahluwalia M; Barnett GH; Deng D; Tatter SB; Laxton AW; Mohammadi AM; Leuthardt E; Chamoun R; Judy K; Asher A; Essig M; Dietrich J; Chiang VL
    J Neurosurg; 2019 Mar; 130(3):804-811. PubMed ID: 29726782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.